Literature DB >> 15309006

Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.

C Michael Gibson1, Sabina A Murphy, David A Morrow, Julian M Aroesty, Raymond J Gibbons, Steven G Gourlay, Hal V Barron, Robert P Giugliano, Elliott M Antman, Eugene Braunwald.   

Abstract

BACKGROUND: Both epicardial and myocardial perfusion have been associated with clinical outcomes in the setting of ST elevation myocardial infarction (STEMI), and the performance of adjunctive/rescue percutaneous coronary intervention (PCI) may further improve clinical outcomes after fibrinolytic administration.
METHODS: The goal was to develop a simple, broadly applicable angiographic metric that takes into account indices of epicardial and myocardial perfusion both before and after PCI to arrive at a single perfusion grade in patients undergoing cardiac catheterization after fibrinolysis. The angiographic perfusion score (APS) is the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG; 0-3) added to the TIMI myocardial perfusion grade (TMPG; 0-3) before and after PCI (total possible grade, 0-12). Failed perfusion was defined as an APS of 0 to 3, partial perfusion was defined as an APS of 4 to 9, and full perfusion was defined as an APS of 10 to 12. The APS was evaluated in patients from the Double-blind, Placebo-contolled, Multicenter Angiographic Trial of Rhumab CD18 in Acute Myocardial Infarction (LIMIT-AMI; n = 394) and Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction-Thrombolysis In Myocardial Infarction (ENTIRE-TIMI) 23 trials (n = 483), and infarct size (120-216 hours after AMI SPECT Technetium-99m Sestamibi data) was assessed in the LIMIT-AMI trial.
RESULTS: The APS was associated with the incidence of death or myocardial infarction (failed, 16.7% [n = 18]; partial, 2.5% [n = 155]; full, 2.4% [n = 82]; P =.039 for trend) and larger SPECT infarct sizes (failed, median 39% [n = 10]; partial, 12% [n = 79]; and full, 8% [n = 35]; P =.002). No patient with full APS died, whereas the mortality rate was 11.1% in patients with a failed APS (P =.03).
CONCLUSIONS: The APS combines grades of epicardial and tissue level perfusion before and after PCI or at the end of diagnostic cardiac catheterization to arrive at a single angiographic variable that is associated with infarct size and the rates of 30-day death or MI. Partial or full angiographic perfusion scores are associated with a halving of infarct size, and no patients with full angiographic perfusion died.

Entities:  

Mesh:

Year:  2004        PMID: 15309006     DOI: 10.1016/j.ahj.2003.12.044

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

Review 1.  Facilitated percutaneous coronary intervention: is this strategy ready for implementation?

Authors:  Derek P Chew; Phil Aylward; Harvey D White
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

2.  Prognostic value of Angiographic Perfusion Score (APS) following percutaneous interventions in acute coronary syndromes.

Authors:  V S Narain; L Fischer; A Puri; R Sethi; S K Dwivedi
Journal:  Indian Heart J       Date:  2012-12-26

3.  The never ending quest for an ideal angiographic surrogate of coronary reperfusion.

Authors:  Vijayakumar Subban; Ajit S Mullasari
Journal:  Indian Heart J       Date:  2012-12-26

4.  Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.

Authors:  Giampaolo Niccoli; Andrea Celestini; Camilla Calvieri; Nicola Cosentino; Elena Falcioni; Roberto Carnevale; Cristina Nocella; Francesco Fracassi; Marco Roberto; Roberta P Antonazzo; Pasquale Pignatelli; Filippo Crea; Francesco Violi
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09-05

5.  No-reflow reversibility: a study based on serial assessment of multiple biomarkers.

Authors:  Giampaolo Niccoli; Francesco Fracassi; Nicola Cosentino; Elena Falcioni; Marco Roberto; Giuseppe De Luca; Antonio Maria Leone; Francesco Burzotta; Italo Porto; Carlo Trani; Anna Severino; Filippo Crea
Journal:  J Cardiovasc Transl Res       Date:  2013-09-06       Impact factor: 4.132

6.  Angiographic perfusion score assessed in patients with acute myocardial infarction is correlated with cardiac magnetic resonance infarct size and N-terminal pro-brain natriuretic peptide in 6-month follow-up.

Authors:  Tomasz Rakowski; Jacek Legutko; Pawel Kleczynski; Agata Brzozowska-Czarnek; Artur Dziewierz; Zbigniew Siudak; Waldemar Mielecki; Andrzej Urbanik; Jacek S Dubiel; Dariusz Dudek
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

7.  Angiographic core laboratory reproducibility analyses: implications for planning clinical trials using coronary angiography and left ventriculography end-points.

Authors:  Terje K Steigen; Cheryl Claudio; David Abbott; Michael Schulzer; Jeff Burton; Wayne Tymchak; Christopher E Buller; G B John Mancini
Journal:  Int J Cardiovasc Imaging       Date:  2007-12-12       Impact factor: 2.357

8.  Association of angiographic perfusion score following percutaneous coronary intervention for ST-elevation myocardial infarction with left ventricular remodeling at 6 weeks in GRACIA-2.

Authors:  JoEllyn M Abraham; C Michael Gibson; Gonzalo Pena; Ricardo Sanz; Amjad AlMahameed; Sabina A Murphy; Jesús Blanco; Juan Alonso-Briales; Juan Lopez-Mesa; Federico Gimeno; Pedro L Sánchez; Francisco Fernández-Avilés
Journal:  J Thromb Thrombolysis       Date:  2008-03-11       Impact factor: 2.300

9.  Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.

Authors:  Yuri B Pride; Jacqueline L Buros; Erin Lord; Matthew C Southard; Caitlin J Harrigan; Lauren N Ciaglo; Marc S Sabatine; Christopher P Cannon; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2007-07-12       Impact factor: 2.300

10.  Association between local interleukin-6 levels and slow flow/microvascular dysfunction.

Authors:  Fangming Guo; Mei Dong; Faxin Ren; Chuanhuan Zhang; Jianping Li; Zhigang Tao; Jun Yang; Guangping Li
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.